Thursday, November 21, 2024
HomeTagsNature Communications

Nature Communications

Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients

Innovent Biologics, Inc. ("Innovent"), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics